| http://www.w3.org/ns/prov#value | - l of renal metabolism.CETP inhibitors are intended to treat patients at risk for atherosclerosis and other cardiovascular diseases by raising high-density lipoprotein cholesterol (HDL-C) and lowering low-density lipoprotein cholesterol (LDL-C) [15].
|
